91精品黑料吃瓜

Introducing Dr. Ari Breiner, the 脡ric Poulin Centre for Neuromuscular Disease Chair in Amyotrophic Lateral Sclerosis (ALS) Clinical Research

Dr. Ari Breiner aims to connect patients, clinicians, and basic science researchers, enabling a flow of research material to scientists and novel treatments to patients.

91精品黑料吃瓜

Dr. Ari Breiner, an assistant professor in 91精品黑料吃瓜鈥檚 Department of Medicine and an attending neurologist at The Ottawa Hospital has been awarded the 脡ric Poulin Centre for Neuromuscular Disease (CNMD) Chair in ALS Clinical Research. The chair was developed with the help of generous donor Margo Brousseau, through the 脡ric Poulin University of Ottawa Centre for Neuromuscular Disease Fund.

Dr. Breiner has already made significant contributions to ALS care, having introduced multi-centre clinical trials in ALS to the Ottawa area, thereby allowing patients to have access to novel therapies locally. In his role as chair, Dr. Breiner plans to expand existing collaborations with 91精品黑料吃瓜 basic scientists, allowing patients to donate biospecimens for research into the basic mechanisms of the disease, and for the development of new treatments. He has also begun to explore the role of neuromuscular imaging studies in the diagnosis and management of the disease. He aims to train national experts in ALS clinical research and develop the CNMD into a national leader in the field.